Literature DB >> 8590602

Determination of the disulfide bond pairings in human tissue factor pathway inhibitor purified from Escherichia coli.

B N Violand1, M R Schlittler, K L Duffin, C E Smith.   

Abstract

The disulfide bond assignments of human alanyl tissue factor pathway inhibitor purified from Escherichia coli have been determined. This inhibitor of the extrinsic blood coagulation pathway possesses three Kunitz-type inhibitor domains, each containing three disulfide bonds. The disulfide bond pairings in domains 1 and 3 were determined by amino acid sequencing and mass spectrometry of peptides derived from a thermolysin digest. However, thermolysin digestion did not cleave any peptide bonds within domain 2. The disulfide bond pairings in domain 2 were determined by isolating it from the thermolysin treatment and subsequently cleaving it with pepsin and trypsin into peptides which yielded the three disulfide bond pairings in this domain. These results demonstrate that the disulfide pairings in each of the three domains of human tissue factor pathway inhibitor purified from Escherichia coli are homologous to each other and also to those in bovine pancreatic trypsin inhibitor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590602     DOI: 10.1007/bf01886791

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  12 in total

Review 1.  Regulation of coagulation by a multivalent Kunitz-type inhibitor.

Authors:  G J Broze; T J Girard; W F Novotny
Journal:  Biochemistry       Date:  1990-08-21       Impact factor: 3.162

Review 2.  Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism.

Authors:  S I Rapaport
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

3.  Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.

Authors:  G J Broze; J P Miletich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.

Authors:  K C Day; L C Hoffman; M O Palmier; K K Kretzmer; M D Huang; E Y Pyla; E Spokas; G J Broze; T G Warren; T C Wun
Journal:  Blood       Date:  1990-10-15       Impact factor: 22.113

5.  Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli.

Authors:  J A Diaz-Collier; M O Palmier; K K Kretzmer; B F Bishop; R G Combs; M G Obukowicz; R B Frazier; G S Bild; W D Joy; S R Hill
Journal:  Thromb Haemost       Date:  1994-03       Impact factor: 5.249

6.  Isolation of Escherichia coli synthesized recombinant eukaryotic proteins that contain epsilon-N-acetyllysine.

Authors:  B N Violand; M R Schlittler; C Q Lawson; J F Kane; N R Siegel; C E Smith; E W Kolodziej; K L Duffin
Journal:  Protein Sci       Date:  1994-07       Impact factor: 6.725

7.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.

Authors:  T J Girard; L A Warren; W F Novotny; K M Likert; S G Brown; J P Miletich; G J Broze
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

8.  Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.

Authors:  E J Haskel; S R Torr; K C Day; M O Palmier; T C Wun; B E Sobel; D R Abendschein
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

9.  Renaturation and purification of human tissue factor pathway inhibitor expressed in recombinant E. coli.

Authors:  M E Gustafson; K D Junger; T C Wun; B A Foy; J A Diaz-Collier; D J Welsch; M G Obukowicz; B F Bishop; G S Bild; R M Leimgruber
Journal:  Protein Expr Purif       Date:  1994-06       Impact factor: 1.650

10.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Authors:  A A Creasey; A C Chang; L Feigen; T C Wün; F B Taylor; L B Hinshaw
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.